Keywords: ahp, rapamune, permits, early, elimination, cyclosporine, treatment
AHP's Rapamune permits early elimination of cyclosporine
Article | 18 May 2000
Treatment with American Home Products' immunosuppressant drugRapamune (sirolimus) permits the elimination of cyclosporine at an early treatment stage, says the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
